NSCLC Biomarker Testing

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

Projects that will be considered for Pfizer support will be Quality Improvement initiatives that analyze and improve biomarker testing practices in NSCLC.

For patients diagnosed with metastatic NSCLC, sub-optimal biomarker testing practices continue to exist. A high percentage of patients are initiated on therapy before the care team receives the results of a comprehensive biomarker testing panel. For some patients, standardized biomarker tests are not performed at all.

Grant support is available to cancer centers or hospitals interested in forming multi-disciplinary teams to analyze their own testing practices and identify areas of improvement using Quality Improvement (QI) methodology such as root cause analysis, Plan Do Study Act (PDSA) cycles etc.

• Grant Application due date: June 23, 2021

Agency Website

Eligibility Requirements

Geographic Scope: United States, Canada and Western Europe

• The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit in the United States, the requesting organization must be accredited.



Amount Description

Individual projects requesting up to $150K will be considered. The estimated total available budget related to this RFP is $450,000.

Funding Type





Curriculum Development
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 23, 2021